A surgical series detailing the results and complications of neuroendoscopy for the treatment of isolated lateral ventricular hydrocephalus (ILVH) has yet to be presented. This retrospective case review of 32 patients examines our experience at the Primary Children’s Medical Center with endoscopic fenestration of the septum pellucidum (septostomy) for ILVH. The patients who underwent endoscopic septostomy between the years of 1993 and 2001 were identified from our database. Forty-three septostomies were performed, with a mean follow-up of 30.9 months. Fifty-three percent of initial septostomies remained patent. Nine patients had a least one more septostomy performed after failure of their initial septostomy. All but one was successful. Including repeat septostomies, 81% of the patients had relief of their ILVH on the last follow-up. No septostomy failures occurred later than 6 months postoperatively. A history of multiple previous shunt procedures was highly predictive of initial septostomy failure, increasing this risk 4.5 times. Complications involved significant intraventricular hemorrhage, wound breakdown, shunt infection and sterile meningitis in four cases. We conclude that endoscopic septostomy is a reasonable treatment option for ILVH, avoiding additional shunts. Outcome is negatively affected by multiple prior shunt procedures. Favorable results can be achieved with repeat septostomies in patients who have failed prior septostomy. Lasting results are expected for septostomies that remain patent after 6 months.

1.
Pople I, Edwards RJ, Aquilina K: Endoscopic methods of hydrocephalus treatment. Neurosurg Clin N Am 2001;36:719–735.
2.
Brockmeyer D, Abtin K, Carey L, Walker ML: Endoscopic third ventriculostomy: An outcome analysis. Pediatr Neurosurg 1998;28:236–240.
3.
Rodziewicz GS, Smith MV, Hodge CJ Jr: Endoscopic colloid cyst surgery. Neurosurgery 2000;46:655–662.
4.
Lewis AI, Keiper GL Jr, Crone KR: Endoscopic treatment of loculated hydrocephalus. J Neurosurg 1995;82:780–785.
5.
Schroeder HW, Gaab MR: Endoscopic acqueductoplasty: Technique and results. Pediatr Neurosurg 1999;45:508–515.
6.
Heilman CB, Cohen AR: Endoscopic ventricular fenestration using a ‘saline torch’. J Neurosurg 1991;74:224–229.
7.
Manwaring KH: Endoscopic ventricular fenestration; in Manwaring KH, Crone KR, Dante MD (eds): Neuroendoscopy. New York, Liebert, 1992, vol 1, pp 81–89.
8.
Grotenhuis JA: Manual of Endoscopic Procedures in Neurosurgery. Nijmegen, Uitgeverij Machaon, 1995.
9.
Walker ML, Petronio J, Carey CM: Ventriculoscopy; in Cheek WR, Marlin AE, McLone DG, Reigel DH, Walker ML (eds): Pediatric Neurosurgery: Surgery of the Developing Nervous System, ed 3. Philadelphia, W.B. Saunders, 1994, pp 572–581.
10.
Brockmeyer DB, Walker ML, Carey C, Lind CC: The role of ventriculoscopy in shunt avoidance, reduction, or elimination in hydrocephalic children (abstract). The American Association of Neurological Surgeons Annual Meeting, Orlando, 1995.
11.
Gangemi M, Maiuri F, Donati PA, Signorelli F, Basile D: Endoscopic surgery for monoventricular hydrocephalus. Surg Neurol 1999;52:246–251.
12.
Oi S, Hidaka M, Honda Y, Togo K, Shinoda M, Shimoda M, Tsugane R, Sato O: Neuroendoscopic surgery for specific forms of hydrocephalus. Childs Nerv Syst 1999;15:56–68.
13.
Hayashi N, Hamada H, Hirashima Y, Kurimoto M, Takaku A, Endo S: Clinical features in patients requiring reoperation after failed endoscopic procedures for hydrocephalus. Minim Invasive Neurosurg 2000;43:181–186.
14.
Gaab MR, Schroeder HWS: Neuroendoscopic approach to intraventricular lesions. J Neurosurg 1998;88:496–505.
15.
Abtin K, Walker ML: Endoscopic management of complex hydrocephalus; in Jimenez DF (ed): Intracranial Endoscopic Neurosurgery. Park Ridge, American Association of Neurological Surgeons Publications Committee, 1998, pp 135–145.
16.
Vinas FC, Castillo C, Diaz FG: Microanatomical considerations for the fenestration of the septum pellucidum. Minim Invasive Neurosurg 1998;41:20–26.
17.
Rhoton AL Jr: Microsurgical anatomy of the lateral ventricles; in Wilkins RH, Rengachary SS (eds): Neurosurgery, ed 2. New York, McGraw-Hill, 1996, pp 1419–1434.
18.
Hopf NJ, Grunert P, Fries G, Resch KDM, Perneczky A: Endoscopic third ventriculostomy: Outcome analysis of 100 consecutive procedures. Neurosurgery 1999;44:795–804.
19.
McComb JG, Zlokovic BV: Cerebrospinal fluid and the blood-brain interface; in McLone DG, Marlin AE, Reigel DH, Scott RM, Walker ML, Steinbok P, Cheek WR (eds): Pediatric Neurosurgery: Surgery of the Developing Nervous System, ed 4. Philadelphia, W.B. Saunders, 2001, pp 180–198.
20.
Kehler U, Gliemroth J, Arnold H: Asymmetric hydrocephalus: Safe endoscopic perforation of septum pellucidum: Technical note. Minim Invasive Neurosurg 1997;40:101–102.
21.
Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Cochrane D, Steinbok P, MacNeil N for the collaborators: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000;33:230–236.
22.
Dawson-Saunders B, Trapp RG: Study designs in medical research; in Dawson-Saunders B, Trapp RG (eds): Basic and Clinical Biostatistics. Norwalk, Appleton & Lange, 1998, pp 6–19.
23.
Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB: Designing Clinical Research: An Epidemiologic Approach, ed 2. Philadelphia, Lippincott Williams & Wilkins, 2001.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.